Do Wearables Give You Accurate HRV? What the Numbers Really Mean

Wearables can measure heart rate variability accurately enough to follow personal trends, especially during quiet rest or sleep. But an accurate HRV reading is not automatically an accurate assessment of recovery, stress, or health. The answer depends on the device, the calculation, the recording conditions, and what you want the number to tell you.

A ring reporting 35 milliseconds and a watch reporting 55 milliseconds may be using different definitions of HRV. Neither reading, by itself, tells you whether your vagus nerve is “strong,” whether you have Long COVID, or whether a relaxation session worked. Understanding wearable HRV accuracy therefore means asking two questions: Was the signal measured well? And is the interpretation justified?

What Is HRV, and How Do Researchers Calculate It?

Heart rate variability, or HRV, describes variation in the time between successive heartbeats. A heart averaging 60 beats per minute does not necessarily beat exactly once every second. Those small timing changes contain information about how cardiovascular regulation responds to breathing, activity, and other demands.

In research, an electrocardiogram, or ECG, identifies the heart’s electrical beats. Researchers check the recordings, handle missed detections and abnormal beats, and calculate variability from normal-to-normal intervals. The 2024 guidelines for human HRV research emphasize that the metric and recording protocol determine what a result means (Quigley et al., 2024).

• RMSSD: Calculate the difference between each pair of consecutive normal intervals, square those differences, average them, and take the square root. Reported in milliseconds, it emphasizes rapid beat-to-beat variation.
• SDNN: Calculate the standard deviation of normal intervals across the recording. It captures variability over that particular observation period.
• Frequency-domain measures: Estimate how much variability occurs at different oscillation frequencies. Interpretation requires knowing the breathing pattern and recording conditions.

Five-minute resting recordings and 24-hour ECG recordings answer different questions. A one-minute SDNN value cannot be judged using a 24-hour SDNN threshold, and RMSSD and SDNN are not interchangeable simply because both use milliseconds.

Why Has HRV Become So Popular in the Past Five Years?

HRV is an established research measure; convenient access is the recent change. Rings and wrist devices now turn repeated overnight measurements into readable trends, while apps translate several signals into daily coaching scores. Oura’s overnight HRV tracking, for example, makes it possible to compare ordinary nights without arranging repeated laboratory visits.

Remote health research has also expanded its relevance. The RECOVER wearable study of Long COVID illustrates how months of home measurements can connect symptoms with everyday physiology. This combination of access, repeated data, and simple feedback helps explain HRV’s visibility. Popularity, however, does not turn it into a universal health score.

What Is the Relationship Between HRV, Mental Health, and Long COVID?

Mental and neurological health: meaningful associations, overlapping values

Brain networks involved in attention, emotion, and stress interact with cardiovascular control. HRV can capture one aspect of this brain–body relationship, alongside influences from sleep, activity, medication, and physical health.

A 2025 umbrella review of HRV in mental disorders covered 21 reviews, 442 primary studies, and 34,625 participants. It found associations between lower HRV and several conditions, including PTSD, schizophrenia, and dementia, although evidence strength varied and none reached the review’s strongest evidence categories (Wang et al., 2025). This supports continued research, rather than diagnosis from an app.

Large human studies show why context matters. In 2,702 Whitehall II participants followed for a decade, lower midlife HRV was associated with faster cognitive decline (Jandackova et al., 2024). Yet an analysis of 15,768 UK Biobank participants identified different autonomic profiles: profiles with low HRV did not have identical associations with depression and suicide risk (Weber et al., 2025).

Results also differ by population. A preregistered study of 1,107 adolescents across three countries did not support the expected broad links between resting HRV, self-regulation, and psychopathology (Sinichi et al., 2025). Together, these findings explain why a group-level association cannot tell you how mentally healthy an individual is.

Long COVID: a useful research signal, not a diagnostic cutoff

Long COVID can involve autonomic symptoms such as orthostatic intolerance, palpitations, and difficulty tolerating exertion. In the 2026 RECOVER analysis of 1,475 adults, higher symptom burden was associated with lower wearable HRV, higher resting heart rate, and lower activity. The adjusted HRV difference was about 4.4 milliseconds—an association across groups, not a threshold for diagnosing an individual (Vogel et al., 2026).

A complementary 2026 meta-analysis of 11 post-COVID studies found that pooled differences in SDNN, RMSSD, and LF/HF were not statistically significant, with substantial variation between studies (Schoene et al., 2026). HRV may therefore contribute to a broader assessment, but normal HRV does not rule out Long COVID, and low HRV does not establish it.

How Do WHOOP, Oura, Fitbit, and Apple Watch Calculate HRV?

Many consumer measurements use photoplethysmography, or PPG: light detects changes in blood volume at the wrist or finger. The resulting pulse intervals can approximate ECG intervals under suitable conditions, but 2026 cardiovascular research guidelines distinguish pulse rate variability from ECG-derived HRV (Carter et al., 2026). Having an ECG feature on a device does not establish that every background HRV value comes from ECG.

Platform descriptions checked October 2026. Models, firmware, regional availability, sampling rules, and algorithms can change. Apple’s announcement distinguishes Recovery HRV from overall HRV but does not specify the Recovery HRV formula in that announcement; it should not simply be relabeled SDNN or RMSSD without supporting documentation.

These scores make several signals easier to interpret together. They can help you notice patterns around sleep and exertion, but the score is a proprietary estimate. A score of 80 on one platform is not equivalent to 80 on another, and it does not measure “80% recovered.”

How Accurate Are Wearable HRV Readings?

The strongest practical case is for consistent measurements during sleep or stillness. Accuracy can change with the metric, device generation, data filtering, and population. A good correlation with ECG is encouraging, but agreement—the size and direction of individual errors—matters more when interpreting a particular reading.

An Oura validation study involving 35 healthy participants found useful agreement for nocturnal RMSSD, while some frequency-domain measures performed less well (Cao et al., 2022). In a larger 2024 Oura study with 114 participants, stricter signal-quality filtering and longer averaging windows improved agreement. Errors were greater in older participants, showing why one average accuracy figure cannot describe every user (Liang et al., 2024).

A 2025 comparison across 536 nights reported mean absolute percentage errors of approximately 6% for Oura Gen 4 and 8% for WHOOP 4.0 against a chest-worn ECG reference. Those nights came from just 13 people, so the result supports those devices in that setting, rather than establishing a universal brand ranking (Dial et al., 2025).

Other platforms illustrate the same need for specificity. A Fitbit Versa 4 pilot involving eight participants reported acceptable overnight agreement, but remains a small validation study (Nasr et al., 2025). Conversely, a study of Apple Watch Series 9 and Ultra 2 found that serial SDNN readings underestimated the reference on average, despite accurate resting heart rate (O’Grady et al., 2024). Accurate heart rate does not guarantee accurate HRV.

These studies used different protocols and generations. They do not establish which current device is “best,” nor automatically validate a 2026 model or a proprietary recovery score. When assessing a claim, look for simultaneous ECG comparison, absolute error, missing-data rates, and participants who resemble the intended users.

What Can Change HRV Besides Your Health?

Breathing changes the signal you are trying to interpret

The 2026 research highlight Interpreting respiratory heart rate variability explains why breathing-related heart-rate oscillations deserve careful interpretation (Sinichi, 2026). It discusses a physiological pattern; it is not a clinical trial showing that a higher wearable score means better health.

The underlying international expert recommendation on respiratory HRV emphasizes the integration of breathing and circulation (Menuet et al., 2025). Breathing rate and depth can change the amplitude and frequency of heart-rate oscillations. At six breaths per minute, the respiratory rhythm is 0.1 Hz—below the conventional high-frequency band of 0.15–0.40 Hz. Respiratory variation can therefore move into the low-frequency band without indicating greater sympathetic activation.

Consequently, a large HRV rise during slow breathing may reflect the breathing maneuver itself. Compare like with like: a paced-breathing session should not be treated as an ordinary resting baseline. The LF/HF ratio is also not a reliable dial showing how much “fight-or-flight” versus “rest-and-digest” activity you have.

Measurement conditions and everyday physiology also matter

The 2026 guidelines on reproducible HRV measurement explain why recording conditions must be controlled. Before interpreting a change, consider three groups of influences:

• The signal: Movement, loose contact, cold skin or reduced peripheral circulation, missed beats, and artifact correction can alter pulse-interval estimates. Excluding noisy periods can also change which parts of the night remain in the average.
• The protocol: Posture, time of day, sleep stage, recording length, and whether the value is a mean, median, or weighted summary all affect comparability.
• The person: Age, underlying heart rate, recent exercise, illness, sleep loss, alcohol, meals, medication, and hormonal changes can influence HRV. A change in medication or routine may explain a new baseline without implying a new disorder.

The goal is not to eliminate normal life. It is to avoid interpreting a measurement change as a health change before checking what else changed.

Is Higher HRV Always Better, and Lower HRV Always Worse?

No. Under comparable resting conditions, a sustained change can be informative, but “higher” is not a universal target. A temporary reduction during exercise or a demanding task can be part of an appropriate response. Breathing differently can raise HRV, while uncorrected ectopic beats or an irregular rhythm can inflate variability without representing healthy regulation.

A more useful question is: Is this unusual for me under similar conditions, and does it fit how I feel and function? Build your comparison around several weeks using the same device and metric. Review the trend alongside resting heart rate, sleep, symptoms, recent activity, and relevant changes in routine.

A single low night usually calls for context. A persistent unexplained shift, especially with palpitations, dizziness, or reduced exercise tolerance, is worth discussing with a clinician. People with Long COVID and post-exertional symptom worsening should not use a favorable readiness score as permission to exceed their established activity limits; CDC guidance on Long COVID care emphasizes symptom-based management.

Does HRV Measure Vagal Tone?

The vagus nerve carries signals between the brain and the body. Cardiac vagal output can rapidly influence the heart’s natural pacemaker, helping explain why resting RMSSD and respiratory HRV are often used as indirect measures of cardiac vagal modulation.

But modulation and tone are different. Modulation describes fluctuations; tone refers to an ongoing level of influence. As explained in Grossman’s 2024 review of respiratory HRV and vagal tone, the size of breathing-related oscillations is not an invariably reliable measure of underlying vagal activity. Breathing, heart rate, and the cardiovascular system’s response to neural input all matter.

HRV and vagal tone are therefore not necessarily positively related in every person or situation. Their relationship can be nonlinear, and a cardiac measurement cannot quantify vagal function throughout the gut, immune system, and brain. ZenoWell’s explanation of the vagus nerve, stress, and recovery provides broader context, but a wearable HRV value should still be treated as one physiological observation.

Does taVNS Increase HRV, and Should We Look at Long-Term Effects?

Transcutaneous auricular vagus nerve stimulation, or taVNS, applies electrical stimulation at the outer ear to engage sensory pathways projecting toward the brainstem. Its downstream effects can involve networks regulating attention, stress responses, and cardiovascular function. This is not equivalent to directly turning up the vagal output to the heart.

Human studies show more than one direction of change

A 2021 Bayesian meta-analysis found no overall acute increase in vagally mediated HRV compared with sham stimulation (Wolf et al., 2021). More recent work reinforces the need to consider the setting: a 2025 randomized crossover study of 36 healthy adults found decreases in several HRV measures during active stimulation (Kaduk et al., 2025).

A 2025 randomized crossover study involving 110 participants, including 59 with major depression, examined responses during an acute stress task. Diagnostic groups did not differ in the effect of taVNS. Exploratory analyses suggested that baseline HRV influenced the response, with HRV decreasing in the higher-baseline group (Schiweck et al., 2025). This is a research lead for personalization, not a validated rule for selecting home stimulation settings.

Repeated treatment can produce different findings. In a randomized trial of 26 women with postural orthostatic tachycardia syndrome (POTS), two months of daily stimulation reduced orthostatic tachycardia and increased high-frequency HRV relative to sham (Stavrakis et al., 2024). Yet the 2025 NoVa-PVC randomized crossover trial reduced premature ventricular contraction burden without a significant between-treatment HRV difference (Zafeiropoulos et al., 2025). A clinically relevant effect and an HRV increase need not occur together.

Long-term assessment needs more than a before-and-after number

Yes—studies should examine repeated use and longer follow-up. They should distinguish changes during stimulation, changes in resting measurements between sessions, and changes that persist after treatment ends. A two-month treatment result does not establish a permanent effect after stopping.

Useful trials would measure ECG-based HRV under matched breathing and posture conditions, compare active treatment with credible sham stimulation, and assess symptoms, function, adverse effects, and adherence over weeks to months. Baseline HRV and stimulation parameters should be prespecified where possible. Wearables can add repeated home observations, while clinical outcomes determine whether the intervention actually helps.

The practical interpretation is that taVNS may influence autonomic regulation in ways that depend on baseline state and context. Neither an immediate HRV rise nor the absence of one can, by itself, prove success or failure. Longer follow-up is a research requirement, not a reason to keep increasing stimulation or use a device indefinitely.

How Can HRV Fit Into a Calmer Evening Routine?

Use tracking to support a manageable routine: regular sleep timing, a quieter transition into the evening, and activity suited to your circumstances. ZenoWell’s guide to everyday ways to calm your nervous system offers a starting point. Judge the routine by sleep, comfort, and daytime functioning as well as wearable trends.

For adults considering an optional device within that routine, ZenoWell Luna Plus uses an ear electrode to deliver gentle electrical pulses and offers Sleep and Relax modes that can be started without an app. The product is designed around 20-minute sessions; its optional Zeno App provides session history and access to wearable heart-rate, HRV, and sleep insights.

That combination can help organize a consistent wind-down habit and record what changes over time. It does not establish that Luna Plus raises HRV or treats depression, POTS, or Long COVID. Follow the device’s instructions and safety information, and compare ordinary resting or overnight readings separately from measurements taken during stimulation or paced breathing.

Frequently Asked Questions

What is a good HRV number?

There is no single wearable HRV target for everyone. The metric, age, recording length, and personal baseline matter. A consistent trend under similar conditions is usually more interpretable than a comparison with someone else.

Can two accurate wearables give different HRV readings?

Yes. They may sample different periods, reject different noisy segments, or report RMSSD versus SDNN. Compare the same metric and conditions before assuming that one is wrong.

Should I try to increase HRV every day?

No. Aim for habits and care that improve how you sleep, feel, and function. HRV can inform that process, but a higher daily reading is not a treatment goal on its own.

References

Apple. (n.d.). heartRateVariabilitySDNN. Retrieved October 31, 2026, from Apple’s HealthKit reference for HRV SDNN.

Apple. (2026, September 9). Apple advances health and fitness capabilities using Apple Intelligence and the most accurate heart rate sensing in a wearable. Retrieved October 31, 2026, from Apple’s announcement of its 2026 health features.

Cao, R., Azimi, I., Sarhaddi, F., Niela-Vilen, H., Axelin, A., Liljeberg, P., & Rahmani, A. M. (2022). Accuracy assessment of Oura Ring nocturnal heart rate and heart rate variability in comparison with electrocardiography in time and frequency domains: Comprehensive analysis. Journal of Medical Internet Research, 24(1), e27487. doi:10.2196/27487

Carter, J. R., Jenkins, N. D. M., Bigalke, J. A., Robinson, A. T., Keller-Ross, M. L., Greaney, J. L., . . . Joyner, M. J. (2026). Guidelines for rigor and reproducibility of heart rate variability within human cardiovascular research. American Journal of Physiology–Heart and Circulatory Physiology, 331(3), H918–H943. doi:10.1152/ajpheart.00041.2026

Centers for Disease Control and Prevention. (2026, March 9). Long COVID clinical guidance. Retrieved October 31, 2026, from CDC’s clinical guidance for Long COVID.

Dial, M. B., Hollander, M. E., Vatne, E. A., Emerson, A. M., Edwards, N. A., & Hagen, J. A. (2025). Validation of nocturnal resting heart rate and heart rate variability in consumer wearables. Physiological Reports, 13(16), e70527. doi:10.14814/phy2.70527

Google. (n.d.-a). Track your heart rate with your Pixel Watch or Fitbit device. Retrieved October 31, 2026, from Google’s heart-rate and HRV support guide.

Google. (n.d.-b). Understanding your readiness score in the Google Health app. Retrieved October 31, 2026, from Google’s guide to the Readiness score.

Grossman, P. (2024). Respiratory sinus arrhythmia (RSA), vagal tone and biobehavioral integration: Beyond parasympathetic function. Biological Psychology, 186, 108739. doi:10.1016/j.biopsycho.2023.108739

Jandackova, V. K., Scholes, S., Britton, A., & Steptoe, A. (2024). Midlife heart rate variability and cognitive decline: A large longitudinal cohort study. International Journal of Clinical and Health Psychology, 24(4), 100518. doi:10.1016/j.ijchp.2024.100518

Kaduk, K., Petrella, A., Müller, S. J., Koenig, J., & Kroemer, N. B. (2025). Non-invasive auricular vagus nerve stimulation decreases heart rate variability independent of caloric load. Psychophysiology, 62(2), e70017. doi:10.1111/psyp.70017

Liang, T., Yilmaz, G., & Soon, C.-S. (2024). Deriving accurate nocturnal heart rate, rMSSD and frequency HRV from the Oura Ring. Sensors, 24(23), 7475. doi:10.3390/s24237475

Menuet, C., Ben-Tal, A., Linossier, A., Allen, A. M., Machado, B. H., Moraes, D. J. A., . . . Gourine, A. V. (2025). Redefining respiratory sinus arrhythmia as respiratory heart rate variability: An international Expert Recommendation for terminological clarity. Nature Reviews Cardiology, 22, 978–984. doi:10.1038/s41569-025-01160-z

Nasr, A., Behbehani, K., Wang, J., Pierson, C., Jarrett, R. B., Greer, T., & Zafereo, J. (2025). Agreement between Fitbit Versa 4 and a reference standard on time-domain nocturnal heart rate variability: A pilot study. Digital Health, 11, 20552076251394960. doi:10.1177/20552076251394960

O’Grady, B., Lambe, R., Baldwin, M., Acheson, T., & Doherty, C. (2024). The validity of Apple Watch Series 9 and Ultra 2 for serial measurements of heart rate variability and resting heart rate. Sensors, 24(19), 6220. doi:10.3390/s24196220

Oura. (2026, October 1). Heart rate variability. Retrieved October 31, 2026, from Oura’s HRV support guide.

Quigley, K. S., Gianaros, P. J., Norman, G. J., Jennings, J. R., Berntson, G. G., & de Geus, E. J. C. (2024). Publication guidelines for human heart rate and heart rate variability studies in psychophysiology—Part 1: Physiological underpinnings and foundations of measurement. Psychophysiology, 61(9), e14604. doi:10.1111/psyp.14604

Schiweck, C., Aichholzer, M., Brandt, E., Schneider, M., Meyer, K., Hamzehloiya, T., . . . Edwin Thanarajah, S. (2025). The heart knows best: Baseline heart rate variability as guide to transcutaneous auricular vagus nerve stimulation in depression. Translational Psychiatry, 15, 521. doi:10.1038/s41398-025-03780-y

Schoene, D., Deckert, S., Barlinn, K., Huttner, H. B., Kösters, M., & Siepmann, T. (2026). Neurocardiac autonomic dysfunction in patients with post-COVID-19 condition: A systematic review and meta-analysis. European Journal of Neurology, 33(3), e70561. doi:10.1111/ene.70561

Sinichi, A. (2026). Interpreting respiratory heart rate variability. Nature Reviews Psychology, 5, 575. doi:10.1038/s44159-026-00601-x

Sinichi, A., Eleftheriou, G., Ha Ngoc, M. A., Kohrt, B. A., Luitel, N. P., Singh, R., . . . Gevonden, M. (2025). Rethinking resting heart rate variability: No evidence of association with self-regulation and psychopathology in a cross-sectional study among adolescents in Colombia, Nepal, and South Africa. Psychophysiology, 62(11), e70184. doi:10.1111/psyp.70184

Stavrakis, S., Chakraborty, P., Farhat, K., Whyte, S., Morris, L., Asad, Z. U. A., . . . Yu, X. (2024). Noninvasive vagus nerve stimulation in postural tachycardia syndrome: A randomized clinical trial. JACC: Clinical Electrophysiology, 10(2), 346–355. doi:10.1016/j.jacep.2023.10.015

Vogel, J. M., Jenkins, T., Cerda, M., Chen, H., Goldman, J., Katz, S. D., . . . Krishnan, J. A. (2026). Sustained reduction in cardiopulmonary fitness in Long COVID: A report from the RECOVER-adult cohort study. JACC: Advances, 5(7), 102923. doi:10.1016/j.jacadv.2026.102923

Wang, Z., Zou, Y., Liu, J., Peng, W., Li, M., & Zou, Z. (2025). Heart rate variability in mental disorders: An umbrella review of meta-analyses. Translational Psychiatry, 15, 104. doi:10.1038/s41398-025-03339-x

Weber, S., Müller, M., Kronenberg, G., Seifritz, E., Ajdacic-Gross, V., & Olbrich, S. (2025). Electrocardiography-derived autonomic profiles in depression and suicide risk with insights from the UK Biobank. npj Mental Health Research, 4, 17. doi:10.1038/s44184-025-00130-0

WHOOP. (2025, September 11). WHOOP Recovery. Retrieved October 31, 2026, from WHOOP’s Recovery documentation.

Wolf, V., Kühnel, A., Teckentrup, V., Koenig, J., & Kroemer, N. B. (2021). Does transcutaneous auricular vagus nerve stimulation affect vagally mediated heart rate variability? A living and interactive Bayesian meta-analysis. Psychophysiology, 58(11), e13933. doi:10.1111/psyp.13933

Zafeiropoulos, S., Coleman, K., Kogan, J., Varrias, D., Leavitt, J., Bekiaridou, A., . . . Mountantonakis, S. (2025). Transcutaneous electrical vagus nerve stimulation to suppress premature ventricular contractions: A crossover, randomized clinical trial (NoVa-PVC). JACC: Clinical Electrophysiology, 11(8), 1699–1707. doi:10.1016/j.jacep.2025.04.011

ZenoWell. (n.d.-a). How to calm your nervous system: Quick techniques, daily habits, and science behind regulation. Retrieved October 31, 2026, from ZenoWell’s guide to calming the nervous system.

ZenoWell. (n.d.-b). Vagus nerve and stress: How recovery really works. Retrieved October 31, 2026, from ZenoWell’s explanation of vagal function and recovery.

ZenoWell. (n.d.-c). ZenoWell Luna Plus. Retrieved October 31, 2026, from the ZenoWell Luna Plus product description.